286
Participants
Start Date
May 7, 2021
Primary Completion Date
July 31, 2024
Study Completion Date
July 31, 2025
Near-infrared spectroscopy (NIRS)
Non invasive brain oxygenation monitoring with Near-Infrared Spectroscopy (NIRS) technology. Patients enrolled in the NeurO2 study will have bilateral NIRS sensors applied to the forehead according to manufacturer recommendations. Data will be monitored continuously throughout the study intervention in the parent trials (HEMOTION and SAHaRA trials) in the neurocritical care unit. Data will be extracted from the device at the end of the study period.
RECRUITING
The Ottawa Hospital, Ottawa
RECRUITING
CHU de Québec - Université Laval (Hôpital de l'Enfant-Jésus), Québec
Collaborators (1)
Ottawa Hospital Research Institute
OTHER
Canadian Critical Care Trials Group
OTHER
Canadian Traumatic Brain Injury Research Consortium
UNKNOWN
CHU de Quebec-Universite Laval
OTHER